The GBM Lunch is aimed at a wide audience, both in terms of professional scope and the level of expertise of the participants. Following the lecture there will be an opportunity for Q&A.

Christopher Carnie (University Hospital Heidelberg, Paediatric Oncology, Immunology & Haematology)
Charting determinants of cellular responses to antimetabolite chemotherapeutics